Glaucoma

Annie Lim, Kelly Muir, Jo Ann Giaconi, Anitra Turner, Crystal Hung, Wanda D. Hu, Laura Vickers, Sally Ong, M. Tariq Bhatti

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Glaucoma is the leading cause of irreversible blindness worldwide. Over the last 3 decades, a series of landmark randomized controlled trials have revealed answers regarding how glaucoma develops, progresses, and is treated. In this chapter, we start with reviewing the Ocular Hypertension Treatment Study, which clarified risk factors for glaucoma development and the role of lowering eye pressure. The Early Manifest Glaucoma Trial and the Collaborative Initial Glaucoma Treatment Study, studied patients with newly diagnosed glaucoma and showed how these patients fare both with and without therapy. The Collaborative Normal Tension Glaucoma Study is a pivotal trial that showed patients with intraocular pressures in the normal range benefit from additional eye pressure lowering. The Advanced Glaucoma Intervention Study evaluated the treatment effect on patients with advanced/severe disease. The final set of clinical trials influenced the techniques of glaucoma intervention. The Glaucoma Laser Trial helped define the role of laser trabeculoplasty in glaucoma treatment. The Fluorouracil Filtering Surgery Study elucidated the benefits and risks of using antimetabolites in trabeculectomy surgery. The Tube Versus Trabeculectomy Study compared the two primary forms of glaucoma surgeries head-to-head and teased out the pros and cons of each. As tube shunt surgery becomes increasingly popular, results from the Ahmed versus Baerveldt and Ahmed Baerveldt Comparison studies allow clinicians to make informed choices regarding which of the two most popular tube shunts to use.

Original languageEnglish (US)
Title of host publicationThe Ophthalmology Clinical Trials Handbook
PublisherNova Science Publishers, Inc.
Pages245-297
Number of pages53
ISBN (Electronic)9781634821049
ISBN (Print)9781634821032
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Glaucoma
Trabeculectomy
Lasers
Low Tension Glaucoma
Filtering Surgery
Therapeutics
Pressure
Antimetabolites
Ocular Hypertension
Blindness
Intraocular Pressure
Fluorouracil
Reference Values
Randomized Controlled Trials
Clinical Trials

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Lim, A., Muir, K., Giaconi, J. A., Turner, A., Hung, C., Hu, W. D., ... Bhatti, M. T. (2015). Glaucoma. In The Ophthalmology Clinical Trials Handbook (pp. 245-297). Nova Science Publishers, Inc..

Glaucoma. / Lim, Annie; Muir, Kelly; Giaconi, Jo Ann; Turner, Anitra; Hung, Crystal; Hu, Wanda D.; Vickers, Laura; Ong, Sally; Bhatti, M. Tariq.

The Ophthalmology Clinical Trials Handbook. Nova Science Publishers, Inc., 2015. p. 245-297.

Research output: Chapter in Book/Report/Conference proceedingChapter

Lim, A, Muir, K, Giaconi, JA, Turner, A, Hung, C, Hu, WD, Vickers, L, Ong, S & Bhatti, MT 2015, Glaucoma. in The Ophthalmology Clinical Trials Handbook. Nova Science Publishers, Inc., pp. 245-297.
Lim A, Muir K, Giaconi JA, Turner A, Hung C, Hu WD et al. Glaucoma. In The Ophthalmology Clinical Trials Handbook. Nova Science Publishers, Inc. 2015. p. 245-297
Lim, Annie ; Muir, Kelly ; Giaconi, Jo Ann ; Turner, Anitra ; Hung, Crystal ; Hu, Wanda D. ; Vickers, Laura ; Ong, Sally ; Bhatti, M. Tariq. / Glaucoma. The Ophthalmology Clinical Trials Handbook. Nova Science Publishers, Inc., 2015. pp. 245-297
@inbook{5b8bd05a7fda42f1af9179fbd01f307c,
title = "Glaucoma",
abstract = "Glaucoma is the leading cause of irreversible blindness worldwide. Over the last 3 decades, a series of landmark randomized controlled trials have revealed answers regarding how glaucoma develops, progresses, and is treated. In this chapter, we start with reviewing the Ocular Hypertension Treatment Study, which clarified risk factors for glaucoma development and the role of lowering eye pressure. The Early Manifest Glaucoma Trial and the Collaborative Initial Glaucoma Treatment Study, studied patients with newly diagnosed glaucoma and showed how these patients fare both with and without therapy. The Collaborative Normal Tension Glaucoma Study is a pivotal trial that showed patients with intraocular pressures in the normal range benefit from additional eye pressure lowering. The Advanced Glaucoma Intervention Study evaluated the treatment effect on patients with advanced/severe disease. The final set of clinical trials influenced the techniques of glaucoma intervention. The Glaucoma Laser Trial helped define the role of laser trabeculoplasty in glaucoma treatment. The Fluorouracil Filtering Surgery Study elucidated the benefits and risks of using antimetabolites in trabeculectomy surgery. The Tube Versus Trabeculectomy Study compared the two primary forms of glaucoma surgeries head-to-head and teased out the pros and cons of each. As tube shunt surgery becomes increasingly popular, results from the Ahmed versus Baerveldt and Ahmed Baerveldt Comparison studies allow clinicians to make informed choices regarding which of the two most popular tube shunts to use.",
author = "Annie Lim and Kelly Muir and Giaconi, {Jo Ann} and Anitra Turner and Crystal Hung and Hu, {Wanda D.} and Laura Vickers and Sally Ong and Bhatti, {M. Tariq}",
year = "2015",
month = "1",
day = "1",
language = "English (US)",
isbn = "9781634821032",
pages = "245--297",
booktitle = "The Ophthalmology Clinical Trials Handbook",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - Glaucoma

AU - Lim, Annie

AU - Muir, Kelly

AU - Giaconi, Jo Ann

AU - Turner, Anitra

AU - Hung, Crystal

AU - Hu, Wanda D.

AU - Vickers, Laura

AU - Ong, Sally

AU - Bhatti, M. Tariq

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Glaucoma is the leading cause of irreversible blindness worldwide. Over the last 3 decades, a series of landmark randomized controlled trials have revealed answers regarding how glaucoma develops, progresses, and is treated. In this chapter, we start with reviewing the Ocular Hypertension Treatment Study, which clarified risk factors for glaucoma development and the role of lowering eye pressure. The Early Manifest Glaucoma Trial and the Collaborative Initial Glaucoma Treatment Study, studied patients with newly diagnosed glaucoma and showed how these patients fare both with and without therapy. The Collaborative Normal Tension Glaucoma Study is a pivotal trial that showed patients with intraocular pressures in the normal range benefit from additional eye pressure lowering. The Advanced Glaucoma Intervention Study evaluated the treatment effect on patients with advanced/severe disease. The final set of clinical trials influenced the techniques of glaucoma intervention. The Glaucoma Laser Trial helped define the role of laser trabeculoplasty in glaucoma treatment. The Fluorouracil Filtering Surgery Study elucidated the benefits and risks of using antimetabolites in trabeculectomy surgery. The Tube Versus Trabeculectomy Study compared the two primary forms of glaucoma surgeries head-to-head and teased out the pros and cons of each. As tube shunt surgery becomes increasingly popular, results from the Ahmed versus Baerveldt and Ahmed Baerveldt Comparison studies allow clinicians to make informed choices regarding which of the two most popular tube shunts to use.

AB - Glaucoma is the leading cause of irreversible blindness worldwide. Over the last 3 decades, a series of landmark randomized controlled trials have revealed answers regarding how glaucoma develops, progresses, and is treated. In this chapter, we start with reviewing the Ocular Hypertension Treatment Study, which clarified risk factors for glaucoma development and the role of lowering eye pressure. The Early Manifest Glaucoma Trial and the Collaborative Initial Glaucoma Treatment Study, studied patients with newly diagnosed glaucoma and showed how these patients fare both with and without therapy. The Collaborative Normal Tension Glaucoma Study is a pivotal trial that showed patients with intraocular pressures in the normal range benefit from additional eye pressure lowering. The Advanced Glaucoma Intervention Study evaluated the treatment effect on patients with advanced/severe disease. The final set of clinical trials influenced the techniques of glaucoma intervention. The Glaucoma Laser Trial helped define the role of laser trabeculoplasty in glaucoma treatment. The Fluorouracil Filtering Surgery Study elucidated the benefits and risks of using antimetabolites in trabeculectomy surgery. The Tube Versus Trabeculectomy Study compared the two primary forms of glaucoma surgeries head-to-head and teased out the pros and cons of each. As tube shunt surgery becomes increasingly popular, results from the Ahmed versus Baerveldt and Ahmed Baerveldt Comparison studies allow clinicians to make informed choices regarding which of the two most popular tube shunts to use.

UR - http://www.scopus.com/inward/record.url?scp=84955688621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955688621&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:84955688621

SN - 9781634821032

SP - 245

EP - 297

BT - The Ophthalmology Clinical Trials Handbook

PB - Nova Science Publishers, Inc.

ER -